scholarly journals The Intrapersonal and Interpersonal Processes of Fear of Recurrence Among Cervical Cancer Survivors - A Qualitative Research.

Author(s):  
Yaira Hamama-Raz ◽  
Shiri Shinan-Altman ◽  
Inbar Levkovich

Abstract Objective: Cervical cancer often takes an emotional and mental toll on the affected woman. Fear of cancer recurrence was identified as one of the most prominent unmet needs in patients and survivors. The present study sought to explore meaning of fear of cancer recurrence among cervical cancer survivors owing to the paucity of studies regarding this population. Methods: In this qualitative research, semi structured interviews conducted with 15 cervical cancer survivors. Interviewees' mean age was 41.33 years (range 34-47 years) and time since diagnosis ranged from six months to seven years (mean - 3.1 years). Results: Three central themes emerged that represent intrapersonal and interpersonal processes that begin with relief from fears of cancer recurrence, alongside acknowledgement of being no longer resilient, representing the intrapersonal level. Next, an interpersonal level that included mutual fears shared by the interviewee and her partner, reflected either by coping together or coping alone. Finally, fear of recurrence became a combination of intrapersonal and interpersonal processes manifested by the greatest fear - death, expressed by both the interviewee and her family members. Conclusions: The present findings revealed that the meaning of fear of cancer recurrence represents intrapersonal and interpersonal processes encompassing three factors – uncertainty, social-cognitive processing and death anxiety. Accordingly, potential psycho-social treatment options could be tailored specific to the dominance of these factors for cervical cancer survivor.

2017 ◽  
Vol 28 (6) ◽  
Author(s):  
Jitti Hanprasertpong ◽  
Alan Geater ◽  
Ingporn Jiamset ◽  
Laaong Padungkul ◽  
Phongchawee Hirunkajonpan ◽  
...  

2018 ◽  
Vol 24 (2) ◽  
pp. 12-19 ◽  
Author(s):  
Tri Wijayanti ◽  
Yati Afiyanti ◽  
Hayuni Rahmah ◽  
Ariesta Milanti

Background: Fear of cancer recurrence is a long-term psychological problem of the cancer survivors regardless of the type of cancer. A growing number of studies had addressed fear of cancer recurrence, yet they are largely focused on the breast cancer survivors of the western world countries. This study investigates the fear of cancer recurrence and its relations to social support in Indonesian gynecological cancer survivors. Methods: Gynecological cancer survivors (n = 153) in Samarinda, East Kalimantan, Indonesia completed Fear of Cancer Recurrence Inventory, Interpersonal Support Evaluation List, socio-demographic and clinically-related characteristics questionnaires. Pearson r correlation tests, t-tests, and ANOVAs were used to identify the relationships between variables, and linear regression to determine to what extent the social support may predict the survivors? fear of recurrence. Results: Indonesian gynecological cancer survivors with higher social support were more likely to experience lower levels of fear of cancer recurrence. Whereas, having a family history of cancer was an important predictor of fear of cancer recurrence levels. Conclusion: Social support plays an essential role in predicting fear of cancer recurrence among Indonesian gynecological cancer survivors.


2021 ◽  
Vol 4 (3) ◽  
pp. 46
Author(s):  
Yohei Sasaki ◽  
Mina Honyashiki ◽  
Takayuki Kinoshita ◽  
Akira Matsui ◽  
Ayako Nakashoji ◽  
...  

The fear of cancer recurrence (FCR) is the most common and most severe unmet need among cancer survivors. Safe treatments for the FCR that are easily disseminated are greatly needed. Our primary aim is a preliminary evaluation of the efficacy and effect size of perilla oil, which is rich in omega-3 fatty acids, and Bifidobacterium, a probiotic, on FCR in breast cancer survivors after the completion of chemotherapy. This study has been planned as an exploratory clinical study (phase II) and will be conducted as a three-arm, 12-week parallel group, masked-rater randomized controlled trial. Fifteen participants will be randomized with 1:1:1 allocation to receive Bifidobacterium plus perilla oil, Bifidobacterium alone, or no intervention (control). Interventions will end within 12 weeks after the random allocation of each participant. The participants will be outpatients with invasive breast cancer aged 20 years or older whose chemotherapy was completed at least 6 months before registration; hormone therapy may be ongoing. The primary outcome will be severity of FCR at 12 weeks assessed by masked raters using the 4-item Concerns about Recurrence Scale concerning overall fear of recurrence. The study protocol for the current study is registered in the Japan Registry of Clinical Trials (jRCTs031200029).


Author(s):  
R Mahendran ◽  
JL Liu ◽  
S Kuparasundram ◽  
S Simard ◽  
YH Chan ◽  
...  

Cancer ◽  
2021 ◽  
Author(s):  
Lidia Schapira ◽  
Yue Zheng ◽  
Shari I. Gelber ◽  
Philip Poorvu ◽  
Kathryn J. Ruddy ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document